Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

XOMA Royalty (XOMA) Research & Development (2016 - 2025)

XOMA Royalty's Research & Development history spans 10 years, with the latest figure at $69000.0 for Q3 2025.

  • For Q3 2025, Research & Development fell 91.55% year-over-year to $69000.0; the TTM value through Sep 2025 reached $2.3 million, up 12.72%, while the annual FY2024 figure was $2.9 million, 1910.49% up from the prior year.
  • Research & Development for Q3 2025 was $69000.0 at XOMA Royalty, roughly flat from $69000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.3 million in Q1 2025 and bottomed at $25000.0 in Q3 2023.
  • The 5-year median for Research & Development is $42000.0 (2021), against an average of $251210.5.
  • The largest YoY upside for Research & Development was 3818.18% in 2025 against a maximum downside of 94.06% in 2025.
  • A 5-year view of Research & Development shows it stood at $42000.0 in 2021, then tumbled by 33.33% to $28000.0 in 2022, then dropped by 10.71% to $25000.0 in 2023, then surged by 3356.0% to $864000.0 in 2024, then plummeted by 92.01% to $69000.0 in 2025.
  • Per Business Quant, the three most recent readings for XOMA's Research & Development are $69000.0 (Q3 2025), $69000.0 (Q2 2025), and $1.3 million (Q1 2025).